Febuxostat and Fibrin d dimer increased - a phase IV clinical study of FDA data

Summary:

Fibrin d dimer increased is reported as a side effect among people who take Febuxostat (febuxostat), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Ambisome, and have Renal cell carcinoma.

The phase IV clinical study analyzes which people have Fibrin d dimer increased when taking Febuxostat. It is created by eHealthMe based on reports of 9,653 people who have side effects when taking Febuxostat from the FDA, and is updated regularly.

What is Febuxostat?

Febuxostat has active ingredients of febuxostat. eHealthMe is studying from 9,693 Febuxostat users. Check the latest studies of Febuxostat.

What is Fibrin d dimer increased?

Fibrin d dimer increased is found to be associated with 518 drugs and 835 conditions by eHealthMe. Check the latest studies of Fibrin d dimer increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

9,653 people reported to have side effects when taking Febuxostat.
Among them, 16 people (0.17%) have Fibrin d dimer increased.

Could Febuxostat cause Fibrin d dimer increased?

Among these 16 people:

How long have people been on Febuxostat when they have Fibrin d dimer increased? *

What is the gender of people who have Fibrin d dimer increased when taking Febuxostat? *

female: 37.5 %
male: 62.5 %

What is the age of people who have Fibrin d dimer increased when taking Febuxostat? *

What are other drugs people take besides Febuxostat? *

Blincyto: 4 people, 25.00%
Ambisome: 4 people, 25.00%
Dexamethasone: 3 people, 18.75%
Crestor: 3 people, 18.75%
Zortress: 2 people, 12.50%
Lansoprazole: 2 people, 12.50%
Dexamethasone Sodium Phosphate: 2 people, 12.50%
Darzalex: 2 people, 12.50%
Nifedipine: 2 people, 12.50%
Cortril: 2 people, 12.50%

What are other side effects people have besides Fibrin d dimer increased? *

Thrombocytopenia (decrease of platelets in blood): 9 people, 56.25%
Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 6 people, 37.50%
Fever: 5 people, 31.25%
Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 4 people, 25.00%
Arterial Haemorrhage: 4 people, 25.00%
White Blood Cell Count Decreased: 4 people, 25.00%
Muscle Haemorrhage (bleeding in muscle): 4 people, 25.00%
Renal Haemorrhage (bleeding from kidney): 4 people, 25.00%
Cough: 3 people, 18.75%
Constipation: 3 people, 18.75%

What are the existing conditions these people have? *

B Precursor Type Acute Leukaemia (lymphoid cancer): 4 people, 25.00%
Renal Cell Carcinoma (a kidney cancer): 4 people, 25.00%
High Blood Pressure: 3 people, 18.75%
Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 18.75%
Gout (uric acid crystals building up in the body): 2 people, 12.50%
Fracture Pain: 2 people, 12.50%
Multiple Myeloma (cancer of the plasma cells): 2 people, 12.50%
Constipation: 2 people, 12.50%
Itching: 2 people, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Febuxostat and have Fibrin d dimer increased?

- Check whether Fibrin d dimer increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Febuxostat:

Febuxostat (9,693 reports)

Browse all side effects of Febuxostat:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fibrin d dimer increased:

Fibrin d dimer increased (518 drugs)

Browse all the conditions that are associated with Fibrin d dimer increased:

Fibrin d dimer increased (835 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on febuxostat (the active ingredients of Febuxostat) and Febuxostat (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.